Phase I, Pharmacokinetic, Safety and Tolerability Study in Healthy Volunteers
- First Posted Date
- 2018-05-11
- Last Posted Date
- 2019-02-26
- Lead Sponsor
- Mycenax Biotech Inc.
- Target Recruit Count
- 190
- Registration Number
- NCT03522012
- Locations
- π¦πΊ
Nucleus Network, Melbourne, Victoria, Australia
A Multicentre Study to Evaluate the Efficacy and Safety of ENIA11 in Patients With Ankylosing Spondylitis
- First Posted Date
- 2016-02-19
- Last Posted Date
- 2019-03-12
- Lead Sponsor
- Mycenax Biotech Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT02685904
- Locations
- π¨π³
Chang Gung Memorial Hospital, Taoyuan, Taiwan
π¨π³Taipei Veterans General Hospital, Taipei, Taiwan
π¨π³Kaohsiung Medical University Chung-Ho Memorial Hospital, Kaohsiung, Taiwan
A Prospective, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicentre, Phase III Study to Evaluate the Efficacy and Safety of ENIA11 in Combination With DMARDs Versus DMARDs Alone in Patients With Rheumatoid Arthritis
- First Posted Date
- 2013-02-08
- Last Posted Date
- 2018-04-17
- Lead Sponsor
- Mycenax Biotech Inc.
- Target Recruit Count
- 98
- Registration Number
- NCT01787149
- Locations
- π¨π³
Mackay Memorial Hospital Institutional, Taipei, Taiwan
π¨π³National Taiwan University Hospital, Taipei, Taiwan
π¨π³Cheng Hsin General Hospital, Taipei, Taiwan
A Phase III Study to Evaluate the Efficacy and Safety of ENIA11 in Combination With Methotrexate Versus Methotrexate Alone in Patients With RA
- First Posted Date
- 2012-10-18
- Last Posted Date
- 2018-04-17
- Lead Sponsor
- Mycenax Biotech Inc.
- Target Recruit Count
- 91
- Registration Number
- NCT01709760
- Locations
- π¨π³
Taichung Veterans General Hospital, Taichung, Taiwan
π¨π³Changhua Christian Hospital, Changhua, Taiwan
π¨π³Buddhist Tzu Chi General Hospital, Chiayi City, Taiwan
Β© Copyright 2024. All Rights Reserved by MedPath